Overview: High-Sensitivity C-Reactive Protein (hsCRP) TestIntroduction: The High-Sensitivity C-Reactive Protein Test measures hsCRP to assess heart disease risk, causing chest pain or shortness of breath. Following 2023 AHA guidelines, it uses an immunoassay for high sensitivity, aiding in cardiovascular screening. This test is critical for guiding risk assessment, preventive strategies, and improving outcomes in immunology for patients with suspected cardiovascular conditions.
Other Names: hsCRP Assay, Cardiac Inflammation Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: hsCRP testing began in the 1990s with cardiovascular risk research. High-sensitivity immunoassays emerged in the 2000s, improving risk stratification accuracy.
Purpose: Assesses heart disease risk, guides preventive measures, and monitors hsCRP levels in patients with chest pain or shortness of breath.
Test Parameters: 1. High-Sensitivity C-Reactive Protein
Pretest Condition: Fasting for 10-12 hours required to stabilize hsCRP levels. Collect serum or plasma after overnight fasting. Report symptoms like chest pain or shortness of breath, and list medications like statins.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document chest pain, shortness of breath, or family history of heart disease. Include current medications, especially statins or anti-inflammatories.
Consent: Written consent required, detailing the tests purpose, implications for heart disease risk, and potential need for preventive therapy.
Procedural Considerations: Uses an immunoassay to measure hsCRP levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting samples, infections, or inflammation may elevate hsCRP levels. Hemolysis can degrade samples.
Clinical Significance: Elevated hsCRP levels indicate increased heart disease risk, prompting lifestyle changes or statins. Normal levels support ongoing monitoring.
Specialist Consultation: Consult a cardiologist for result interpretation. A lipidologist referral is advised for complex cases.
Additional Supporting Tests: Lipid profile, Apo B test, or coronary artery calcium scan to assess cardiovascular risk comprehensively.
Test Limitations: Results may be affected by non-cardiac inflammation. Clinical correlation is required.
References: AHA Lipid Guidelines, 2023; Circulation, Ridker PM, 2022.
